Your browser doesn't support javascript.
loading
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile.
van der Wagen, Lotte E; Miranda-Bedate, Alberto; Janssen, Anke; Fernando, Febilla; Appukudige, Nagesha; van Dooremalen, Sanne; Westinga, Kasper; Admiraal, Rick; Lorenowicz, Magdalena J; Huls, Gerwin; Janssen, Jeroen J W M; Broers, Annoek E C; van der Velden, Walter J F M; van Marwijk Kooy, Rien; Hazenberg, Mette D; de Haar, Colin; Lindemans, Caroline; Jan Boelens, Jaap; Kuball, Jürgen.
Afiliação
  • van der Wagen LE; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Miranda-Bedate A; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Janssen A; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Fernando F; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Appukudige N; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • van Dooremalen S; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Westinga K; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Admiraal R; Cell Therapy Facility, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Lorenowicz MJ; Pediatric Blood and Marrow Transplant Program Prinses Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands.
  • Huls G; Center for Molecular Medicine and Regenerative Medicine Center UMC Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Janssen JJWM; Department of Hematology, UMC Groningen, Groningen, the Netherlands.
  • Broers AEC; Department of Hematology, Amsterdam University Medical Centers, loc. VUmc Amsterdam, Amsterdam, the Netherlands.
  • van der Velden WJFM; Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.
  • van Marwijk Kooy R; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
  • Hazenberg MD; Department of Internal Medicine, Isala klinieken Zwolle, Zwolle, the Netherlands.
  • de Haar C; Department of Hematology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands.
  • Lindemans C; Cell Therapy Facility, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Jan Boelens J; Department of Hematology, Princess Maxima Centrum, Utrecht, the Netherlands.
  • Kuball J; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Bone Marrow Transplant ; 55(11): 2188-2192, 2020 11.
Article em En | MEDLINE | ID: mdl-32346077
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Doença Enxerto-Hospedeiro Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Doença Enxerto-Hospedeiro Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda